Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
389K
-
Shares change
-
+389K
-
Total reported value, excl. options
-
$1.67M
-
Value change
-
+$1.67M
-
Number of buys
-
8
-
Price
-
$4.30
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q4 2019
9 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q4 2019.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 389K shares
of 107M outstanding shares and own 0.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (160K shares), BlackRock Inc. (100K shares), GEODE CAPITAL MANAGEMENT, LLC (51.9K shares), OXFORD ASSET MANAGEMENT LLP (41.3K shares), DIMENSIONAL FUND ADVISORS LP (11.9K shares), WINTON GROUP Ltd (11K shares), Leap Investments LP (10.8K shares), MORGAN STANLEY (1.71K shares), Alyeska Investment Group, L.P. (62.5K shares), and Advisor Group, Inc. (160 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.